Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

MicroRNA-107 inhibits U87 glioma stem cells growth and invasion.

Chen L, Chen XR, Chen FF, Liu Y, Li P, Zhang R, Yan K, Yi YJ, Xu ZM, Jiang XD.

Cell Mol Neurobiol. 2013 Jul;33(5):651-7. doi: 10.1007/s10571-013-9927-6. Epub 2013 Apr 10.

PMID:
23572380
2.

Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.

Wang W, Long L, Wang L, Tan C, Fei X, Chen L, Huang Q, Liang Z.

Cancer Lett. 2016 Feb 28;371(2):274-84. doi: 10.1016/j.canlet.2015.12.012. Epub 2015 Dec 17.

PMID:
26706414
3.

Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma LN, Xu SL, Yang L, Wang QL, Dang WQ, Cui W, Yu SC, Ping YF, Cui YH, Kung HF, Qian C, Zhang X, Bian XW.

Oncogene. 2015 Mar 12;34(11):1407-19. doi: 10.1038/onc.2014.75. Epub 2014 Apr 7.

PMID:
24704830
4.

Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.

Wan Y, Fei XF, Wang ZM, Jiang DY, Chen HC, Yang J, Shi L, Huang Q.

Chin J Cancer. 2012 Apr;31(4):207-14. doi: 10.5732/cjc.011.10336. Epub 2012 Feb 24.

5.

A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.

Kim RK, Kim MJ, Yoon CH, Lim EJ, Yoo KC, Lee GH, Kim YH, Kim H, Jin YB, Lee YJ, Cho CG, Oh YS, Gye MC, Suh Y, Lee SJ.

Mol Pharmacol. 2012 Sep;82(3):400-7. doi: 10.1124/mol.112.078402. Epub 2012 May 30.

6.

MiR-218-5p inhibits the stem cell properties and invasive ability of the A2B5⁺CD133⁻ subgroup of human glioma stem cells.

Wu Z, Han Y, Li Y, Li X, Sun T, Chen G, Huang Y, Zhou Y, Du Z.

Oncol Rep. 2016 Feb;35(2):869-77. doi: 10.3892/or.2015.4418. Epub 2015 Nov 13.

PMID:
26572167
7.

CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.

Zheng J, Li XD, Wang P, Liu XB, Xue YX, Hu Y, Li Z, Li ZQ, Wang ZH, Liu YH.

Oncotarget. 2015 Sep 22;6(28):25339-55. doi: 10.18632/oncotarget.4509.

8.

Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells.

Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, Sze J, Leung GK, Lu G, Chan DT, Bian XW, Kung HF, Poon WS, Lin MC.

J Biol Chem. 2012 Mar 23;287(13):9962-71. doi: 10.1074/jbc.M111.332627. Epub 2012 Jan 17.

9.

The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.

Huang TT, Ping YH, Wang AM, Ke CC, Fang WL, Huang KH, Lee HC, Chi CW, Yeh TS.

Oncotarget. 2015 Jul 20;6(20):18012-26.

10.

MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.

Yao Y, Ma J, Xue Y, Wang P, Li Z, Li Z, Hu Y, Shang X, Liu Y.

Mol Oncol. 2015 Mar;9(3):640-56. doi: 10.1016/j.molonc.2014.11.003. Epub 2014 Nov 20.

11.

TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.

Di K, Linskey ME, Bota DA.

Oncogene. 2013 Oct 17;32(42):5038-47. doi: 10.1038/onc.2012.531. Epub 2012 Nov 26.

12.

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.

Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG.

Stem Cells. 2010 Jan;28(1):5-16. doi: 10.1002/stem.254.

13.

MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.

Xu D, Ma P, Gao G, Gui Y, Niu X, Jin B.

Tumour Biol. 2015 Sep;36(10):7743-53. doi: 10.1007/s13277-015-3378-2. Epub 2015 May 4.

PMID:
25936342
14.

microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma.

An L, Liu Y, Wu A, Guan Y.

PLoS One. 2013 Jul 23;8(7):e69478. doi: 10.1371/journal.pone.0069478. Print 2013.

15.

miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.

Guo M, Jiang Z, Zhang X, Lu D, Ha AD, Sun J, Du W, Wu Z, Hu L, Khadarian K, Shen J, Lin Z.

Carcinogenesis. 2014 Aug;35(8):1698-706. doi: 10.1093/carcin/bgu030. Epub 2014 Jan 30.

PMID:
24480809
16.
17.

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma.

Zhang C, Zhang J, Hao J, Shi Z, Wang Y, Han L, Yu S, You Y, Jiang T, Wang J, Liu M, Pu P, Kang C.

J Transl Med. 2012 Jun 8;10:119. doi: 10.1186/1479-5876-10-119.

18.

microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.

Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S.

Int J Oncol. 2012 Mar;40(3):747-56. doi: 10.3892/ijo.2011.1242. Epub 2011 Oct 24.

PMID:
22025269
19.

miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.

Wu N, Xiao L, Zhao X, Zhao J, Wang J, Wang F, Cao S, Lin X.

FEBS Lett. 2012 Nov 2;586(21):3831-9. doi: 10.1016/j.febslet.2012.08.023. Epub 2012 Sep 18.

20.

Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal.

Lee HK, Finniss S, Cazacu S, Bucris E, Ziv-Av A, Xiang C, Bobbitt K, Rempel SA, Hasselbach L, Mikkelsen T, Slavin S, Brodie C.

Oncotarget. 2013 Feb;4(2):346-61.

Supplemental Content

Support Center